Summary:
Summary Statement of Deficiencies D2010 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(2) (b)(2) The laboratory must test samples the same number of times that it routinely tests patient samples. This STANDARD is not met as evidenced by: Based on review of the laboratory's American Proficiency Institute (API) proficiency testing (PT) documentation and interview, the laboratory failed to test proficiency samples the same number of times that it routinely tests patient samples. Findings: 1. Review of the laboratory's 2026 API PT documentation found the laboratory was testing API PT samples multiple times. One sample was analyzed for 6 regulated analytes of the Complete Blood Count (CBC): Red Bloodcell Count (RBC), Hemoglobin, Hematocrit, Platelet, White Bloodcell Count (WBC), and WBC auto differential. 2. The sample XE-02 from API Event 1, was tested two times. 3. The laboratory policy, Proficiency Testing Policy Prohibitions Regarding PT Samples states "Proficiency testing specimens must be handled in the same manner, to the extent practicable, as are patient specimens. 'For example, if the proficiency specimen result is within your critical range, and you have a written policy that you would repeat a patient specimen in this range, then repeat the proficiency specimen. If you would not repeat a patient specimen, do not repeat testing on the proficiency specimen." 4. No documentation for the reason of the repeated testing was provided at survey. The general supervisor #1 (GS#1) response was she was unaware running a PT sample multiple times was not allowed per CMS PT program and laboratory's policy . 5. Interview with GS#1 on 9/17/26 at 9:30 a.m. confirmed, the laboratory failed to test proficiency samples the same number of times that it routinely tests patient samples. 55063 Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --